EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Track record

Tools

  • Compare
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›CLRO

CLRO

CLEARONE INC

Next earnings Aug 12, 2026

Hold
$3.14
▼ -0.31%
$3.14▼ -45.86%
over 1Y
L $2.72EODHDH $11.91
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-0.3%
1W-7.1%
1M-2.5%
3M-17.4%
YTD-40.5%
1Y-45.9%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
F
Valuation
Fair value
Filings
Flagged
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Buy

High return on equity (3653.2%).

CLEARONE INC shows $0.00 in FY2025 revenue, and 3653.2% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$29.0M$25.2M$18.7M$0.00$0.00
Gross profit$11.9M$9.46M$6.36M-$194K-$328K
Operating income-$7.50M-$7.22M-$6.77M-$2.13M-$4.40M
Net income-$7.69M$20.6M-$560K-$8.98M-$26.1M
Diluted EPS-$0.39$0.83-$0.02-$5.61-$14.77
Net margin-26.6%81.6%-3.0%——

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$8.18M
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-310.5%
FCF yield-175.6%

Quality & risk

ROIC (est.)—
Free cash flow-$14.8M
Total debt$0.00
Net cash$220K
Altman Z-Score-26.54 distress
Piotroski F-Score3/8

Capital returns

Buyback yield1.7%
Dividend yield (est.)0.0%
Shareholder yield1.7%
Shares Δ YoY-89.7%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Red flag in recent filings — delisting notice (2026-04-13). Worth a closer look.
  1. S-3 Shelf registration (potential raise)2026-06-25
  2. 10-Q Quarterly report2026-05-15
  3. 8-K Charter / bylaws change2026-04-23
  4. 8-K Delisting notice2026-04-13
  5. 8-K Officer / director change2026-04-03
  6. 10-K Annual report2026-03-31
  7. 8-K Shareholder vote2026-03-17
  8. 8-K Material agreement2026-03-13
  9. 8-K Material agreement2026-03-05

Recent filings

all on EDGAR ↗
S-3Filing2026-06-25open ↗10-QPeriod ending 2026-03-312026-05-15open ↗8-KPeriod ending 2026-04-232026-04-23open ↗8-KPeriod ending 2026-04-132026-04-13open ↗8-KPeriod ending 2026-04-032026-04-03open ↗DEF 14CPeriod ending 2026-03-312026-03-31open ↗10-KPeriod ending 2025-12-312026-03-31open ↗8-KPeriod ending 2026-03-172026-03-17open ↗PRE 14CPeriod ending 2026-03-172026-03-17open ↗8-KPeriod ending 2026-03-132026-03-13open ↗SCHEDULE 13D/AFiling2026-03-06open ↗4Period ending 2026-03-022026-03-06open ↗

Quality score

F
ValueGrowthProfitHealthMom.
Value—
GrowthF
Profitability—
Financial healthF
Momentum—
  • ✗Profitable (positive net income)
  • ✓Liabilities below 2× equity
Revenue
$0.00
Net margin
—
ROE
—
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$0.00
Net income-$26.1M-190.4%
Gross profit-$328K-69.1%
Operating income-$4.40M-105.9%
Diluted EPS-$14.77-163.3%
Cash & equivalents$220K-84.5%
Total assets$2.30M-91.3%
Total liabilities$3.01M-42.2%
Stockholders' equity-$714K-103.3%
L/E: -4.22x

Frequently asked

Is CLEARONE INC (CLRO) a buy?
CLRO currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. High return on equity (3653.2%).
What is CLEARONE INC's quality score?
CLRO scores 18.999999999999996/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000840715, latest 10-Q filed 2026-05-15) · EODHD · as of 6/24/2026, 1:20:52 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-03-02
First Finance Ltd.
10% owner
Buy438K @ $4.00$1.75M
2025-11-24
BAGLEY EDWARD D
10% owner
Sell700K @ $3.00$2.10M
2025-02-26
BAGLEY EDWARD D
10% owner
Buy2.00M @ $0.50$1.00M
2023-12-14
BAGLEY EDWARD D
10% owner
Buy9.54K @ $0.82$7.85K
2023-12-13
BAGLEY EDWARD D
10% owner
Buy4.02K @ $0.81$3.26K
2023-12-12
BAGLEY EDWARD D
10% owner
Buy11.6K @ $0.81$9.32K
2023-12-11
BAGLEY EDWARD D
10% owner
Buy14.2K @ $0.81$11.5K
2023-12-06
BAGLEY EDWARD D
10% owner
Buy10.5K @ $0.79$8.28K

Dividends

Irregular
Yield (TTM)
—
Annual / share
—
Last ex-date
2024-04-11
Last amount
$7.50
ex 2024-04-11paid 2024-04-10$7.50
ex 2023-06-01paid 2023-05-31$15.00
ex 2018-03-06paid 2018-03-21$1.05
ex 2017-11-21paid 2017-12-06$1.05
ex 2017-08-18paid 2017-09-07$1.05
ex 2017-05-15paid 2017-05-31$1.05

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2025-05-19—▲ +4.85%8-K ↗
2025-03-31—▼ -7.90%8-K ↗
2024-11-15—▼ -10.67%8-K ↗
2024-08-15—▼ -5.74%8-K ↗
2024-05-21—▲ +0.17%8-K ↗
2024-04-03—▼ -8.88%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
XSD Delivers 1,138% in Ten Years, Yet Trails SOXX in the AI BoomBullish
finance.yahoo.com· 2026-05-04
The Zacks Analyst Blog Highlights SAP, Novartis, Philip Morris International, ImmuCell and ClearOneBullish
finance.yahoo.com· 2025-10-09
Top Stock Reports for SAP, Novartis & Philip MorrisBullish
finance.yahoo.com· 2025-10-08
Friday's after hours session: top gainers and losersBullish
chartmill.com· 2025-09-05
Which stocks are moving before the opening bell on Monday?Bullish
chartmill.com· 2025-08-25
Stocks Moving Premarket: PPCB, BTAI, TNXP, DAY, TPIC, And Other Gainers & LosersBullish
nasdaq.com· 2025-08-18

Vs tracked universe

compare →

1044 tracked peers · median

EDGAR Score19 vs 67
Revenue growth— vs 7.1%
Net margin— vs 10.5%
Return on equity— vs 12.3%
P/E— vs 25.5